BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹303 Cr | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr |
What is the latest Revenue of BAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹303 Cr |
| Mar2024 | ₹339 Cr |
| Mar2023 | ₹304 Cr |
| Mar2022 | ₹281 Cr |
| Mar2021 | ₹251 Cr |
How is Revenue of BAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹303 Cr | -10.65 | |
| Mar2024 | ₹339 Cr | 11.51 | |
| Mar2023 | ₹304 Cr | 8.18 | |
| Mar2022 | ₹281 Cr | 12.25 | |
| Mar2021 | ₹251 Cr | - | |
Compare Revenue of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹118.2 Cr | 6.9% | 4.6% | -35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 6.9% |
4.6% |
-35.9% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses